,title,source,link,date
1,Glenmark Life Sciences Limited Proposes Final Dividend for the Financial Year 2022-2023,Marketscreener.com,news.google.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?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
8,Stocks that will see action today: 1 September 2023,BusinessLine,news.google.com/articles/CBMic2h0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3N0b2Nrcy10aGF0LXdpbGwtc2VlLWFjdGlvbi10b2RheS0xLXNlcHRlbWJlci0yMDIzL2FydGljbGU2NzI1ODU1NS5lY2XSAXhodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbWFya2V0cy9zdG9ja3MtdGhhdC13aWxsLXNlZS1hY3Rpb24tdG9kYXktMS1zZXB0ZW1iZXItMjAyMy9hcnRpY2xlNjcyNTg1NTUuZWNlL2FtcC8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
48,"Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia",FiercePharma,news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3Z5dmFuc2UtZ2VuZXJpY3MtYW5vdGhlci1sZW52aW1hLWZsb3AtYWRhZ2VuZS1hZGMtYnJlYWt1cNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
54,"Pregabalin Market Business Share, Size, New Opportunities and Forecast 2029",openPR,news.google.com/articles/CBMiW2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMTkxODY1L3ByZWdhYmFsaW4tbWFya2V0LWJ1c2luZXNzLXNoYXJlLXNpemUtbmV3LW9wcG9ydHVuaXRpZXPSAVpodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMTkxODY1L3ByZWdhYmFsaW4tbWFya2V0LWJ1c2luZXNzLXNoYXJlLXNpemUtbmV3LW9wcG9ydHVuaXRpZXM?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
69,"Allergic Rhinitis Pipeline Assessment, 2023 Updates: FDA, EMA ...",Digital Journal,news.google.com/articles/CBMi6QFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9nZXRuZXdzL2FsbGVyZ2ljLXJoaW5pdGlzLXBpcGVsaW5lLWFzc2Vzc21lbnQtMjAyMy11cGRhdGVzLWZkYS1lbWEtYW5kLXBtZGEtYXBwcm92YWxzLWVtZXJnaW5nLWRydWdzLWNsaW5pY2FsLXRyaWFscy10aGVyYXBldXRpYy1hbmFseXNpcy1hbmQtZ3Jvd3RoLXByb3NwZWN0cy1pbHRvby1waGFybWEtcmV2b2xvLWJpb3RoZXJhcGV1dGljc9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-31
19,"Glenmark, Baxter issue separate recalls for hypertension and cancer ...",FiercePharma,news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9nbGVubWFyay1iYXh0ZXItaXNzdWUtc2VwYXJhdGUtcmVjYWxscy1oeXBlcnRlbnNpb24tYW5kLWNhbmNlci1kcnVnc9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
40,"Pharma sector Q1 review: Growth led by US market, gRevlimid sales; India growth slips on price cuts, muted volumes",The Financial Express,news.google.com/articles/CBMiqgFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9idXNpbmVzcy9pbmR1c3RyeS1waGFybWEtc2VjdG9yLXExLXJldmlldy1ncm93dGgtbGVkLWJ5LXVzLW1hcmtldC1ncmV2bGltaWQtc2FsZXMtaW5kaWEtZ3Jvd3RoLXNsaXBzLW9uLXByaWNlLWN1dHMtbXV0ZWQtdm9sdW1lcy0zMjI0NTQ0L9IBrwFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9idXNpbmVzcy9pbmR1c3RyeS1waGFybWEtc2VjdG9yLXExLXJldmlldy1ncm93dGgtbGVkLWJ5LXVzLW1hcmtldC1ncmV2bGltaWQtc2FsZXMtaW5kaWEtZ3Jvd3RoLXNsaXBzLW9uLXByaWNlLWN1dHMtbXV0ZWQtdm9sdW1lcy0zMjI0NTQ0L2xpdGUv?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
46,Adalimumab Biosimilar Market Report Analysis (2023-2030 ...,Digital Journal,news.google.com/articles/CBMilAFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy90aGVleHByZXNzd2lyZS9hZGFsaW11bWFiLWJpb3NpbWlsYXItbWFya2V0LXJlcG9ydC1hbmFseXNpcy0yMDIzLTIwMzAtZm9ydHVuZS1idXNpbmVzcy1pbnNpZ2h0cy10cmFkZS1wdnQtbHRk0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
33,Fierce Pharma Asia—Moderna's cancer combo plan; GSK's trial win ...,FiercePharma,news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21vZGVybmEtdmFjY2luZS1jYXItdC1jb21iby1wbGFucy1zaGluZ3JpeC0xMDAtZWZmaWNhY3ktZ2xlbm1hcmstZG9qLWRlYWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
74,SSWCMA approves 29 projects proposals worth Rs. 1483 crore,himachal headlines,news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LmhpbWFjaGFsaGVhZGxpbmVzLmNvbS9idXNpbmVzcy9zc3djbWEtYXBwcm92ZXMtMjktcHJvamVjdHMtcHJvcG9zYWxzLXdvcnRoLXJzLTE0ODMtY3JvcmUv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
